Advertisement

Immunogenicity of Surfactant and Its Implications for Replacement Therapy

  • D. S. Strayer
  • T. A. Merritt
  • R. Spragg
  • M. Hallman
Conference paper

Abstract

The etiology and pathogenesis of neonatal and adult respiratory distress syndromes (RDS) differ widely but share the characteristic inability of the lungs to adequately oxygenate the blood. Neonatal RDS occurs in premature infants deficient in surfactant (SRF) [1]. SRF deficiency causes alveoli to collapse on expiration, resulting in progressive respiratory failure. Because neonatal RDS directly reflects deficiency of surfactant, various investigators have tried therapeutic administration of heterologous, artificial, and homologous surfactants [2–4]. These preparations generally lower surface tension in vitro and in animal models, and are reported to be efficacious in infants with RDS.

Keywords

Immune Complex Adult Respiratory Distress Syndrome Pulmonary Surfactant Congenital Toxoplasmosis Neonatal Respiratory Distress Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Farrell PM, Avery ME (1975) Hyaline membrane disease. Am Rev Respir Dis 111: 657–669PubMedGoogle Scholar
  2. 2.
    Fujiwara T, Maeta J, Chida S, Morita T, Watabe Y, Abe A (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1: 55–59PubMedCrossRefGoogle Scholar
  3. 3.
    Morley CJ, Miller N, Bangham AD, Davis JA (1983) Dry artificial lung surfactant and its effect on very premature babies. Lancet 1: 64–68Google Scholar
  4. 4.
    Hallman M, Merritt TA, Schneider H, Epstein BL, Manino F, Edwards DK, Gluck L (1983) Isolation of human surfactant from amniotic fluid and pilot study of its efficacy in respiratory distress syndrome. Pediatrics 71: 473–482PubMedGoogle Scholar
  5. 5.
    Strayer DS, Merritt TA, Lwebuga-Mukasa J, Hallman M (1986) Surfactant-antisurfactant immune complexes in infants with respiratory distress syndrome. Am J Pathol 122: 353–362PubMedGoogle Scholar
  6. 6.
    Engvall E, Pesce A (eds) (1981) Quantitative enzyme immunoassay. Scand J Immunol [Suppl 7]Google Scholar
  7. 7.
    Enhorning G (1977) Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43: 198PubMedGoogle Scholar
  8. 8.
    Hallman M, Epstein B, Gluck L (1981) Analysis of labeling and clearance of lung surfactant phospholipids in the rabbit. J Clin Invest 68: 742–751PubMedCrossRefGoogle Scholar
  9. 9.
    Rott IM, Donaich D (1976) Gastric autoimmunity. In: Miescher PA, Muller-Eberhard HJ (eds) Textbook of immunopathology. Grune and Stratton, New York, pp 737–747Google Scholar
  10. 10.
    Thivolet J, Beyvin AJ (1968) Recherches par immunofluorescence d’autoanticorps serique vis-a-vis des constitutuents de l’épiderme chez les brulés. Experientia 24: 945–946PubMedCrossRefGoogle Scholar
  11. 11.
    Jeffries AL, Coates G, O’Brodovich H (1984) Pulmonary epithelial permeability in hyaline-membrane disease. N Engl J Med 311: 1075–1080CrossRefGoogle Scholar
  12. 12.
    Bauer H, Waters TJ, Talano JV (1972) Antimyocardial antibodies in patients with coronary heart disease. Am Heart J 83: 612–619PubMedCrossRefGoogle Scholar
  13. 13.
    Zabriskie JB, Hsu KC, Seegal BC (1970) Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol 7: 147–159PubMedGoogle Scholar
  14. 14.
    Sack W, Sebvening H, Wachsmuth ED (1975) Auto-Antikörper gegen Herzmuskelsarkolemm im Serum von Patienten mit primärer Cadriomyopathie. Klin Wochenschr 53: 103–110PubMedCrossRefGoogle Scholar
  15. 15.
    Camp TF, Hess EV, Conway G, Fowler NO (1969) Immunologic findings in idiopathic cardiomyopathy. Am Heart J 77: 610–617PubMedCrossRefGoogle Scholar
  16. 16.
    Trueman T, Thompson RA, Cummins P, Littler WA (1981) Heart antibodies in cardiomyopathies. Br Heart J 46: 296–301PubMedCrossRefGoogle Scholar
  17. 17.
    Silverstein AM (1972) Fetal immune responses in congenital infection. N Engl J Med 286: 1413–1414PubMedCrossRefGoogle Scholar
  18. 18.
    Gitlin D, Biasucci A (1969) Development of yG, yA, yM, B1cBlA, C’1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, α-antitrypsin, orosomucoid, ß-lipoprotein, α-macroglobulin, and prealbumin in the human conceptus. J Clin Invest 48: 1433–1446PubMedCrossRefGoogle Scholar
  19. 19.
    Stiehm ER, Ammann AJ, Cherry JD (1966) Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med 275: 971–977PubMedCrossRefGoogle Scholar
  20. 20.
    Alford CA, Schaefer J, Blankenship WJ et al (1966) A correlative immunologic, microbiologic and clinical approach to the diagnosis of acute and chronic infections in newborn infants. N Engl J Med 277: 437–449CrossRefGoogle Scholar
  21. 21.
    Remington JS (1969) The present status of the IgM fluorescent antibody technique in the diagnosis of congenital toxoplasmosis. J Pediatr 75: 1116–1124PubMedCrossRefGoogle Scholar
  22. 22.
    Aase JM, Noren GR, Reddy V, St. Geme JW Jr (1972) Mumps-virus infection in pregnant women and the immunologic response of their offspring. N Engl J Med 286: 1377–1382CrossRefGoogle Scholar
  23. 23.
    Field EJ, Caspary EA (1971) Is maternal lymphocyte sensitization passed to the child? Lancet ii: 337–341CrossRefGoogle Scholar
  24. 24.
    Leikin S, Oppenheim JJ (1971) Prenatal sensitization. Lancet ii: 876–877CrossRefGoogle Scholar
  25. 25.
    Cramer DV, Kunz HW, Gill TJ III (1974) Immunololgic sensitization prior to birth. Am J Obstet Gynecol 120: 431–439PubMedGoogle Scholar
  26. 26.
    Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol Inst Pasteur 125C: 373–389Google Scholar
  27. 27.
    Rodkey LS (1980) Autoregulation of immune responses via idiotype network interactions. Microbiol Rev 44: 631–659PubMedGoogle Scholar
  28. 28.
    Bona C, Paul WE (1979) Cellular basis of regulation of expression of idiotype: I. T-suppressor cells specific for MOPC-460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med 149: 592–600PubMedCrossRefGoogle Scholar
  29. 29.
    Strayer DS, Kohler H (1976) Immune response to phosphorylcholine II, natural “auto”anti-receptor antibody in neonatal Balb/c mice. Cell Immunol 25: 294–301PubMedCrossRefGoogle Scholar
  30. 30.
    Shahani SK, Hattikudor NS (1981) Immunological consequences of vasectomy. Arch Androl 7: 193–199PubMedCrossRefGoogle Scholar
  31. 31.
    Wallace RB, Lee J, Gerber WL, Clarke WE, Lauer RM (1981) Vasectomy and coronary artery disease in men less than 50 years old: absence of association. J Urol 126: 182–184PubMedGoogle Scholar
  32. 32.
    Kapp JA, Strayer DS (1978) H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin. J Immunol 121: 978–982PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • D. S. Strayer
  • T. A. Merritt
  • R. Spragg
  • M. Hallman

There are no affiliations available

Personalised recommendations